Tao Du is listed as a director on 1 SEC Form D filing by 1 issuer in Jan 2022: IVIEW Therapeutics, Inc. (Cranbury, NJ — biotechnology — 2022; $30M reported sold to 15 investors).
What this means One deal on file with the SEC, filed Jan 2022. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Bin He (1 shared filing), Bo Liang (1 shared filing), John J Baldwin (1 shared filing), Qi Zhu (1 shared filing), Wei Wang (1 shared filing) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Tao. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Tao Du and found 3 differences: Offering amount changed between filings; Same name, different state: "Tao Du" (PA) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.